Can ibrutinib be used as a first-line treatment in CLL?
The power of venetoclax
MURANO trial: revolutionizing the standard of care for relapsed CLL patients
Exciting drug developments in chronic lymphocytic leukemia (CLL)
Expanding trials using bispecifics